Beroni Group Limited
BNIGF
Get informed when a big investor buys or sells
+ FollowMarket Cap$212.76K
Close$
Share Statistics
| Market cap | $212,760.00 |
|---|---|
| Enterprise Value | $3.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.13 |
| Beta | -1.76 |
| Outstanding Shares | 34,372,935 |
Return
| Return on Equity | -427.43% |
|---|---|
| Return on Assets | -198.18% |
| Return on Invested Capital | -255.05% |
Valuation & Multiples
| P/E Ratio | -0.13 |
|---|---|
| PEG | 0.64 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.01 |
| Enterprise Value to EBIT | -0.18 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.11 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beroni Group Limited
5 employees
CEO: Boqing Zhang Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is...